2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Pocket Pal
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee
Abstract

Research Snapshot Theater: Sepsis/Infectious Disease, Adult

Monday, March 23, 2026
10:15 AM - 11:15 AM Central Time
Location: Connections Central - RST 16

    RST Moderator(s)

  • BF

    Bruce Friedman, MD, FCCP, CNSP

    Critical Care and Co-Director JM Still Burn Center
    Joseph M Still Burn Center at Doctors Hospital, Georgia

    Disclosure(s): No relevant financial relationship(s) to disclose.

  • Matt McKenzie, PharmD (he/him/his)

    University of Texas MD Anderson Cancer Center, Texas

    Disclosure(s): No relevant financial relationship(s) to disclose.

Presentations:

  • 10:15 AM - 11:15 AM Central Time
    Likelihood of Bacterial Infection in Immunocompromised Patients Treated With IV Antibiotics

    Simran Gupta, MD (she/her/hers) – Brigham and Women's Hospital

    Lucia Millham, MD – Brigham and Women's Hospital

    Chanu Rhee, MD, MPH, FCCM (he/him/his) – Harvard Medical School

    Michael Klompas, MD – Brigham and Women's Hospital

  • 10:15 AM - 11:15 AM Central Time
    Impact of Time to Antibiotics on Mortality in Immunocompromised Patients With Sepsis Syndromes

    Simran Gupta, MD (she/her/hers) – Brigham and Women's Hospital

    Michael Klompas, MD – Brigham and Women's Hospital

    Anna Agan, N/A – Brigham and Women's Hospital

    Laura DelloStritto, MPH – Harvard Pilgrim Health Care Institue

    Caroline Mckenna, N/A – Brigham and Women's Hospital

    Andre Kalil, Select Member MD (he/him/his) – University of Nebraska Medical Center

    Chanu Rhee, MD, MPH, FCCM (he/him/his) – Harvard Medical School

  • 10:15 AM - 11:15 AM Central Time
    Subphenotypes of Infection Site and Organ Failure Predict Mortality in Adults With Sepsis in Africa

    Phoebe Gruccio, n/a (she/her/hers)

    Reagan Kakande, n/a – Mbarara University of Science and Technology Department of Medicine

    Louisa Edwards, n/a – Stanford University, Department of Management Science and Engineering

    Muhammad Zulfiqar, n/a – UVA School of Medicine, Division of Infectious Diseases and International Health

    Michael Ndyomugabe, n/a – Mbarara University of Science and Technology Department of Medicine

    Victor Adejayan, n/a – UVA School of Medicine, Division of Infectious Diseases and International Health

    Philemon Ojuman, n/a – Mbarara University of Science and Technology Department of Medicine

    William S. Girard, n/a – UVA School of Medicine, Division of Infectious Diseases and International Health

    Eva Otoupalova, MD – Tulane University School of Medicine

    Paulin R. Banguti, n/a – University of Rwanda, Department of Anesthesia

    Dennis Hopkinson, n/a – University of Rwanda, Department of Anesthesia

    Jean Paul Mvukiyehe, n/a – University of Rwanda, Department of Anesthesia

    Cozie Gwaikolo, n/a – JFK Hospital, Department of Medicine

    Richard Ssekitoleko, N/A – WHO Uganda

    Elisabeth D. Riviello, n/a – Harvard University

    Edwin Nuwagira, N/A – Mbarara University of Science and Technology Department of Medicine

    Christopher C. Moore, MD – UVA School of Medicine, Division of Infectious Diseases and International Health

  • 10:15 AM - 11:15 AM Central Time
    Effect of Rapid Sepsis Test Adoption on Mortality, Discharge, Hospital-Free Days & Cultures in 4 EDs

    Christopher Thomas, MD

    John Bruchhaus, MD – St. Francis Medical Center

    Richard Bush, MD – St. Dominic's Hospital

    Bradley Burns, MD – St. Dominic's Hospital

    Douglas Clement, MD – Our Lady of Lourdes Hospital

    Christopher Trevino, MD – Our Lade of The Lake Ascension

    Teresa Daniel, RN-BC – St. Francis Medical Center

    Sarah Abdeen, PA – St. Dominic's Hospital

    Alyse Grantham, MBA – Our Lady of The Lake Regional Medical Center

    Kristen Richard, MSN, RN – Our Lady of The Lake Regional Medical Center

    Matt Sorrells, PhD – Cytovale Inc.

    Tonya Jagneaux, MD, MSHI, FCCP – Our Lady of The Lake Regional Medical Center/ LSU Health Sciences Center

    Hollis O'Neal, MD, MSc – Our Lady of The Lake Regional Medical Center/ LSU Health Sciences Center

  • 10:15 AM - 11:15 AM Central Time
    Case Report of Rapidly Fatal Serratia marcescens Necrotizing Fasciitis

    Catherine Doubek, AGACNP-BC (she/her/hers) – Washington University in Saint Louis School of Medicine

  • 10:15 AM - 11:15 AM Central Time
    Empiric Antifungal Therapy for Critically Ill Patients With Candidemia

    Chandni Vashee, MD

    Konstantinos Ouranos, MD – Department of Medicine, Houston Methodist Hospital, Houston, TX USA

    Vinayika Papineni, MD – Department of Medicine, Houston Methodist Hospital, Houston, TX USA

    Aarjav Sanghvi, N/A – Center of Health Data Science and Analytics, Houston Methodist Hospital, Houston, TX, USA

    Wesley Hoffman, PharmD – Department of Pharmacy, Houston Methodist Hospital, Houston, TX USA

    Max Adelman, MD, MS – Division for Pulmonary Critical Care, and Sleep Medicine; Division for Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, TX USA; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX USA

  • 10:15 AM - 11:15 AM Central Time
    Antibiotic De-escalation and 30-Day Mortality in Culture-Negative Sepsis

    Tetsu Ohnuma, MD, MPH, PhD (he/him/his) – Duke University

    Matthew Fuller, MS – Duke University

    Poojitha Balamurugan, MS – Duke University

    Vijay Krishnamoorthy, MD, PhD – Duke University

    Karthik Raghunathan, MBBS, MPH – Duke University

    Miriam M. Treggiari, MD, PhD, MPH – Duke University School of Medicine